CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL

Peereboom, D., Lindsay, R., Badruddoja, M., Nabors, L. B., Kumthekar, P., Lieberman, F., Tran, D., Phuphanich, S., Schiff, D., Sherman, J., Butowski, N., Dunbar, E., Fink, K., Iwamoto, F., Moertel, C., Schulder, M., Walbert, T., Habboubi, N., Grzegorzewski, K., … Reardon, D. A. (2022). CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL. Neuro-Oncology, 24(Supplement_7), vii67–vii67. https://doi.org/10.1093/neuonc/noac209.261
Authors:
David M. Peereboom
Ross Lindsay
Michael Badruddoja
Burt Nabors
Priya Kumthekar
Frank S. Lieberman
David Tran
Surasak Phuphanich
David Schiff
Jonathan H. Sherman
Nicholas Butowski
Priya Kumthekar
Karen Fink
Fabio Iwamoto
Christopher L. Moertel
Michael Schulder
Tobias Walbert
Nassir Habboubi
Krzysztof Grzegorzewski
Christopher Brooks
David A. Reardon
Affiliated Authors:
Fabio Iwamoto
Columbia Affiliation:
Subjects:
Immunobiology of Dendritic Cells (OpenAlex Topic)
Comprehensive Integration of Single-Cell Transcriptomic Data (OpenAlex Topic)
Macrophage Activation and Polarization (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac209.261
DOI:
10.1093/neuonc/noac209.261
Journal:
Neuro-Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: